Mitie shareholders overwhelmingly approved a takeover by CD&R-owned rival OCS on 16 September, leaving regulatory clearances as the main hurdle before the facilities group leaves the stock market early next year.

Mitie Group (LSE: MTO), one of the UK's largest facilities management and outsourcing businesses, is moving towards the end of its life as a listed company. At court and general meetings held on 16 September, investors voted decisively in favour of a recommended cash takeover by OCS Group, a rival facilities services provider owned by funds advised by private equity firm Clayton, Dubilier & Rice. With shareholder approval secured, the focus has shifted to regulatory sign-off and court sanction, and the scheme is expected to become effective in the first quarter of 2027.

Overwhelming backing from investors

At the court meeting, 99.74% of the votes cast supported the scheme, with almost 95% of the individual shareholders who voted backing it. The special resolution at the general meeting was approved by 99.76% of votes. Those results satisfy the shareholder conditions set out in the scheme document dated 13 August, which also confirmed that the timetable was unchanged.

The level of support is unsurprising given the terms. When the deal was announced on 21 July, OCS agreed to pay 218.5p in cash for each Mitie share. Shareholders were also entitled to keep a final dividend of 3.1p for the year to March 2026, which was approved at the annual meeting that day and scheduled for payment in late August, bringing the total value to as much as 221.6p. That valued Mitie at around £3.1bn on a fully diluted basis and represented a premium of about 45% to the closing price of 151p on 20 July, and around 18% to the company's all-time closing high of 185.7p set in April.

The board, advised by Ardea Partners and Peel Hunt, unanimously recommended the offer, arguing that it provided immediate and certain cash value compared with the uncertain timing of returns from its standalone strategy. Chairman Chris Rogers described the deal as an attractive outcome for shareholders. If completion slips beyond 19 November, the directors may also pay an interim dividend of up to 1.3p for the current financial year.

The industrial logic and the regulatory test

OCS argues that combining the two UK-headquartered businesses, with combined 2025 revenues of roughly £8.5bn, will create greater scale and breadth across government, defence, healthcare and national infrastructure contracts. It has said it plans to invest in technology, data and artificial intelligence, as well as training and apprenticeships, and has committed to safeguard employees' contractual and pension rights. The acquisition is funded through equity from CD&R funds and debt arranged by banks including HSBC, RBC and Barclays.

The main outstanding issue is regulatory clearance. Because the deal brings together two major facilities providers, competition scrutiny is a key consideration. The offer documents state that if regulators demand remedies that would be materially adverse to OCS, including a scenario involving an in-depth Phase 2 review by the Competition and Markets Authority that the parties do not both agree to, OCS would seek Takeover Panel consent to let the offer lapse. The long stop date is 21 July 2027.

Trading below the offer price

Mitie shares have continued to trade at a modest discount to the offer value. On 1 October, chief financial officer Simon Kirkpatrick exercised long-term incentive options and sold shares at 210p to cover the associated tax, a price around 4% below the cash terms, reflecting the time until completion and regulatory uncertainty.

Operationally, the business entered the offer period in good shape. Its first-quarter update on 21 July reported continued momentum, with double-digit revenue growth, building on the acquisition of security and compliance group Marlowe in 2025.